CD4/CD8 ratio and lung cancer risk - Authors' reply
Lancet HIV
.
2017 Mar;4(3):e103-e104.
doi: 10.1016/S2352-3018(17)30026-7.
Authors
Keith Sigel
1
,
Robert Dubrow
2
Affiliations
1
Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: keith.sigel@mssm.edu.
2
Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, USA.
PMID:
28254147
DOI:
10.1016/S2352-3018(17)30026-7
No abstract available
Publication types
Letter
Comment
MeSH terms
CD4-CD8 Ratio*
CD4-Positive T-Lymphocytes
HIV Infections*
Humans
Lung
Lung Neoplasms